130 related articles for article (PubMed ID: 2396896)
21. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
22. Experimental tests of hypotheses about neurochemical mechanisms underlying behavioral tolerance to the anticholinesterase, diisopropyl fluorophosphate.
Russell RW; Overstreet DH; Cotman CW; Carson VG; Churchill L; Dalglish FW; Vasquez BJ
J Pharmacol Exp Ther; 1975 Jan; 192(1):73-85. PubMed ID: 164530
[TBL] [Abstract][Full Text] [Related]
23. Variation of commercial diisopropyl fluorophosphate preparations in toxicological studies.
Ho IK; Hoskins B
Drug Chem Toxicol; 1983; 6(5):421-7. PubMed ID: 6628264
[TBL] [Abstract][Full Text] [Related]
24. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
25. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
26. DFP induced changes in acetylcholinesterase activity and glycogen level in certain brain regions of mice.
Husain K; Vijayaraghavan R
Indian J Physiol Pharmacol; 1989; 33(4):250-2. PubMed ID: 2620969
[TBL] [Abstract][Full Text] [Related]
27. Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity.
Cook WO; Beasley VR; Dahlem AM; Dellinger JA; Harlin KS; Carmichael WW
Toxicon; 1988; 26(8):750-3. PubMed ID: 3188065
[TBL] [Abstract][Full Text] [Related]
28. Acute and delayed effects of diisopropyl fluorophosphate on body temperature, heart rate, and motor activity in the awake, unrestrained rat.
Gordon CJ
J Toxicol Environ Health; 1993 Jun; 39(2):247-60. PubMed ID: 8501768
[TBL] [Abstract][Full Text] [Related]
29. Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats.
Baireddy P; Mirajkar N; Nallapaneni A; Singleton N; Pope CN
Arch Toxicol; 2007 Apr; 81(4):283-9. PubMed ID: 16944100
[TBL] [Abstract][Full Text] [Related]
30. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
31. Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury.
Li Y; Lein PJ; Liu C; Bruun DA; Giulivi C; Ford GD; Tewolde T; Ross-Inta C; Ford BD
Toxicol Appl Pharmacol; 2012 Jul; 262(2):194-204. PubMed ID: 22583949
[TBL] [Abstract][Full Text] [Related]
32. Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
Dawson RM
Neurochem Int; 1995 Jun; 26(6):643-54. PubMed ID: 7670367
[TBL] [Abstract][Full Text] [Related]
33. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
Tien LT; Fan LW; Ma T; Loh HH; Ho IK
J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
[TBL] [Abstract][Full Text] [Related]
34. Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides.
Henderson JD; Glucksman G; Leong B; Tigyi A; Ankirskaia A; Siddique I; Lam H; DePeters E; Wilson BW
J Biochem Mol Toxicol; 2012 Jan; 26(1):31-4. PubMed ID: 21972196
[TBL] [Abstract][Full Text] [Related]
35. The interaction of carbamates with acetylcholinesterase.
Watts P; Wilkinson RG
Biochem Pharmacol; 1977 Apr; 26(8):757-61. PubMed ID: 558761
[No Abstract] [Full Text] [Related]
36. Vagal tone monitoring: a potential indicator of anti-cholinesterase exposure in Macaca mulatta.
Dellinger JA; Jansen HT; Zaber DJ; Birnbaum SG
Toxicology; 1988 May; 49(2-3):227-35. PubMed ID: 3376129
[TBL] [Abstract][Full Text] [Related]
37. Eptastigmine-phosphotriesterase combination in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
[TBL] [Abstract][Full Text] [Related]
38. Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterases by o-pinacolyl-methylphosphonofluoridate. In vitro experiments with rat tissues.
Patocka J
Biomed Biochim Acta; 1989; 48(9):715-20. PubMed ID: 2619740
[TBL] [Abstract][Full Text] [Related]
39. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
[TBL] [Abstract][Full Text] [Related]
40. Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures.
Wehner JM; Smolen A; Smolen TN; Murphy C
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1104-9. PubMed ID: 4092872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
